PKO Investment Management Joint-Stock’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.4M | Hold |
13,000
| – | – | 0.15% | 109 |
|
2025
Q1 | $1.31M | Buy |
13,000
+3,000
| +30% | +$303K | 0.15% | 105 |
|
2024
Q4 | $893K | Buy |
10,000
+5,000
| +100% | +$447K | 0.11% | 114 |
|
2024
Q3 | $419K | Hold |
5,000
| – | – | 0.05% | 143 |
|
2024
Q2 | $385K | Sell |
5,000
-3,000
| -38% | -$231K | 0.05% | 153 |
|
2024
Q1 | $551K | Sell |
8,000
-4,000
| -33% | -$275K | 0.07% | 143 |
|
2023
Q4 | $694K | Buy |
12,000
+4,000
| +50% | +$231K | 0.09% | 121 |
|
2023
Q3 | $422K | Buy |
+8,000
| New | +$422K | 0.06% | 126 |
|
2023
Q2 | – | Sell |
-10,000
| Closed | -$500K | – | 145 |
|
2023
Q1 | $500K | Sell |
10,000
-7,000
| -41% | -$350K | 0.07% | 127 |
|
2022
Q4 | $787K | Hold |
17,000
| – | – | 0.11% | 109 |
|
2022
Q3 | $658K | Hold |
17,000
| – | – | 0.11% | 105 |
|
2022
Q2 | $634K | Buy |
+17,000
| New | +$634K | 0.09% | 105 |
|